Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants

Since discovering that ketamine has robust antidepressant effects, the glutamatergic system has been proposed as an attractive target for the development of novel antidepressants. Among the glutamatergic system, metabotropic glutamate (mGlu) receptors are of interest because mGlu receptors play modu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaki, Shigeyuki, Koike, Hiroyuki, Fukumoto, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243201/
https://www.ncbi.nlm.nih.gov/pubmed/32500107
http://dx.doi.org/10.1177/2470547019837712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243201/
https://www.ncbi.nlm.nih.gov/pubmed/32500107
http://dx.doi.org/10.1177/2470547019837712

Ejemplares similares